This inventor holds 6 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 3 EPO patents. Top assignees: Guangzhou Cellprotek Pharmaceutical Ltd., Guangzhou Cellprotek Pharmaceutical Co., Ltd, Guangzhou Cellprotek Pharmaceuticals Ltd.. Active years: 2014-2020.
Location History:
- Guangdong, CN (2016)
- Guangzhou, CN (2014 - 2020)
Company Filing History:
3 out of 4 
2 out of 10 
1 out of 1 Years Active: 2014-2020
Title: **The Innovative Contributions of Inventor Pengxin Qiu**
Introduction
Pengxin Qiu, based in Guangzhou, China, is a notable inventor with a total of six patents to his name. His work primarily focuses on neuro-protective agents, particularly in the context of altitude sickness caused by hypobaric hypoxia. This innovative research promises to significantly impact the field of medicine, addressing critical health issues related to high altitudes.
Latest Patents
One of Pengxin Qiu's most significant patents involves the use of 5α-androstane-3β,5,6β-triol and its analogs in developing a new drug aimed at preventing or treating altitude sickness. The research indicates that this treatment effectively reduces vasogenic edema in brain tissue caused by hypobaric hypoxia. It helps lower the increased cerebral water content and protects neuronal health, thereby improving neurological dysfunction associated with altitude sickness. This advancement not only highlights Qiu's expertise but also opens new avenues for medical treatment in individuals exposed to high-altitude environments.
Career Highlights
Throughout his career, Pengxin Qiu has worked with reputable organizations such as Guangzhou Cellprotek Pharmaceutical Ltd. and Guangzhou Cellprotek Pharmaceutical Co., Ltd. His contributions to these companies reflect a commitment to advancing pharmaceutical innovations, particularly in neuroprotection and treatment for altitude-related conditions.
Collaborations
In his journey, Pengxin Qiu has collaborated with esteemed colleagues, including Guangmei Yan and Jingxia Zhang. These partnerships have played a crucial role in enhancing the research output and innovation in developing neuro-protective agents, thereby pushing the boundaries of what is possible in this vital area of healthcare.
Conclusion
Pengxin Qiu stands out as an influential inventor whose research has the potential to transform how altitude sickness is treated. With a solid foundation in pharmaceutical innovation and a focus on neuro-protective agents, Qiu's work continues to inspire future advancements in medical science, making him an important figure in the realm of inventions and patents.